Roland Buhl
Institution:
University Hospital Mainz, Germany
Michael Dreher
Institution:
University Hospital Aachen, Germany
Prof. Michael Dreher is the Head of Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen.
Professional Training
2005-2012: Internship, residency, senior residency and consultant at the Department of Pneumology, University Hospital Freiburg
06/2011: German Board Certification for Internal Medicine
08/2011-12/2012: Consultant at the Department of Pneumology, University Hospital Freiburg
06/2012: German Board Certification for Pneumology
01/2013-06/2018: Head of Division of Pneumology, University Hospital Aachen
since 2014: Full Professor of Medicine / Pneumology, University Hospital Aachen
since 07/2018: Head of Department of Pneumology and Intensive Care Medicine, University Hospital Aachen
Felix Herth
Institution:
Department of Pneumology and Critical Care Medicine, University of Heidelberg, Germany
1990 – 1996 Resident; Internal Medicine, Städt. Klinikum Karlsruhe
1996 – 1997 Resident; Dept. of Pulmonology,Thoraxklinik Heidelberg
1997 – 1999 Fellow; Dept. of interdisciplinary Endoscopy and Oncology, Thoraxklinik Heidelberg
1999 – 2003 Ass. Med. Director Dept. of Interdisciplinary Endoscopy and Oncology, Thoraxklinik Heidelberg
2003 Medical Director Experimental Endoscopy, Beth Israel Deaconess Hospital, Harvard Medical School, Boston, USA
Current Position
Since 2004 Head of Department of Internal Medicine, Pulmonology and Critical Care Medicine Thoraxklinik Heidelberg
Speciality certification:
1997 German Board of Internal Medicine certified
1998 Pulmonary Mecidine certified
2000 Bachelor of Economic Health
2002 Professor of Medicine, University of Heidelberg, Germany
2006 Full Professor, University of Heidelberg, Germany
Major Committee Assignments:
2006 Vice-President of European Association for Bronchology and Interventional Pulmonology (EAB)
2009 European Health Leader
2012 Assembly secretary of the European Respiratory Society (ERS)
2012 President of European Association for Bronchology and Interventional Pulmonology (EAB)
2013 Editor in Chief Respiration
Professional Society
German Society of Pulmonology
European Respiratory Society
European Association for Bronchology and Interventional Pulmonology
American Association of Bronchology
World Association of Bronchology
Christoph Lange
Institution:
Medical Clinic Research Center Borstel and University of Lübeck, Germany
He is Honorary Professor at the Karolinska Institute in Stockholm, Sweden, the University of Namibia in Windhoek and the State University of Medicine and Pharmacy of the Republic of Moldova in Chisinau, where he travels regularly for teaching.
Horst Olschewski
Institution:
Sigmund Freud Private University, Vienna, Austria
Horst Olschewski is Professor for Pneumology and Experimental Medicine at the Sigmund Freud Private University in Vienna, and is Senior Professor at the Charité University Medicine in Berlin, Germany.
Najib Rahman
Institution:
Oxford University Hospital, Oxford, UK
Najib Rahman directs the Oxford Respiratory Trials Unit and works clinically as a pleural specialist. Having qualified in Oxford he underwent the medical SHO rotation at Queen’s Medical Centre, Nottingham, and re-joined Oxford as a Specialist Registrar in 2003. He undertook a DPhil and MSc in this period and was appointed Director of the Oxford Respiratory Trials Unit and Consultant Lead for Pleural Disease in Oxford in 2011. He was appointed as Professor of Respiratory Medicine in 2018, and is currently running randomized and observational studies in pleural infection, pneumothorax and malignant pleural effusion. He is trained in Thoracoscopy, Thoracic Ultrasound and Clinical Trials methodology, and has published over 300 papers with citations of >6000 and an H-index of 62. He is co-chair of the BTS Pleural Guidelines 2023, Chair of the BTS Pleural Intervention Committee 2023, Chair of multiple ERS guidelines on pleural disease, Senior NIHR Investigator and National Speciality Lead for Respiratory Research for the UK Clinical Research Network.
Luca Richeldi
Institution:
University Hospital A. Gemelli, Catholic University of the Sacred Heart, Rome, Italy
Dr. Richeldi was also the Founder and Director of the Center for Rare Lung Diseases at the same university. From November 2005 to November 2008 he was the Director of the School of Specialization in Respiratory Medicine of the University of Modena and Reggio Emilia. From November 2012 he was the Deputy Dean for Education of the Faculty of Medicine of the University of Modena and Reggio Emilia. He serves as associate editor for the European Respiratory Journal and is a member of the editorial board of the American Journal of Respiratory and Critical Care Medicine. He is a member of the Microbiology, Tuberculosis and Pulmonary Infections program committee of the American Thoracic Society (ATS). He has been part of the panels in charge of the production of the ATS-ERS guidelines on “Diagnosis of tuberculosis infection” and “Idiopathic pulmonary fibrosis” and is a member and reviewer of the Cochrane Collaboration. Dr. Richeldi is a member of the Fleischner Society and has published more than 100 peer-reviewed papers and contributed several chapters in scientific books.
Amelia Shoemark
Institution:
University of Dundee, Ninewells Hospital and Medical School, Dundee, UK
Professor Amelia Shoemark is Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, where she conducts a translational research program in chronic respiratory disease with a focus on bronchiectasis.
Amelia began her career as a clinical scientist at the Royal Brompton Hospital in London. She set up and led a nationally funded laboratory for the diagnosis of Primary Ciliary Dyskinesia (PCD), a position she still holds part time.
She completed her PhD at Imperial college in 2010 investigating inflammation in the chronic respiratory condition bronchiectasis. She is an active member of the management committee of the European Bronchiectasis clinical research consortium, EMBARC and is chair of the BEAT-PCD European Respiratory Society clinical research consortium.
These translational areas of respiratory research have led to>100 peer review articles and book chapters on bronchiectasis, primary ciliary dyskinesia and mucociliary clearance.
Jacky Smith
Institution:
University of Manchester, Manchester University NHS Foundation, Manchester, UK
Jacky Smith is a Professor of Respiratory Medicine at the University of Manchester, an Honorary Consultant in Respiratory Medicine at Manchester University NHS Foundation Trust and the Director of the Manchester NIHR Clinical Research Facility. She set up and runs a multi-disciplinary team translating neurophysiological mechanisms in cough and facilitating the development of novel therapies. Her research is funded by a Wellcome Investigator Award, UKRI and the Manchester Biomedical Research Centre. She led the development of a cough monitoring system that has been commercialised and changed the standards by which cough medicines are evaluated.
Daiana Stolz
Institution:
University Hospital Freiburg, Germany
Daiana Stolz is Medical Director and University Professor, Clinic of Pneumology, University of Freiburg, Germany.
Johan Vansteenkiste
Institution:
University Hospital Gasthuisberg, Leuven, Belgium
Johan Vansteenkiste is Professor of Internal Medicine in the Faculty of Medicine at the Catholic University of Leuven, Belgium, and Head of Clinic in the Respiratory Oncology Unit and its Clinical Trial Unit at the Leuven University Hospital, Belgium.
Professor Vansteenkiste studied Medicine at the Catholic University of Leuven before becoming a Board Certified Pulmonologist-Oncologist. He had additional training in Respiratory Oncology at the European School of Oncology in Milan, Italy, and in Respiratory Endoscopy at the Laser Centre in Marseille, France, before gaining his PhD at the Catholic University of Leuven in 1996. Professor Vansteenkiste is an active member of different national and international societies such as IASLC, ASCO, ESMO, ERS, and others. He is member of the Board of Directors of IASLC in 2009-2013 and member of the ESMO Lung Educational Group and Guidelines Group. He was Secretary of the Thoracic Oncology Assembly of the ERS and member of the ERS School Board from 2009-2012. He is the principal investigator or co-investigator in several clinical trials in the area of lung cancer. He is Associate Editor at the Journal of Thoracic Oncology, member of the editorial board of the Journal of Clinical Oncology and several other journals, and author or co-author of more than 200 peer-reviewed papers and book chapters on Respiratory Oncology.
Marlies Wijsenbeek-Lourens
Institution:
Erasmus Medical Center, Netherlands
Marlies Wijsenbeek-Lourens is pulmonary physician at the Erasmus University Medical Centre in Rotterdam, a national expert centre for interstitial lung diseases (ILD) in the Netherlands and member of the European Reference Network for Rare Lung Diseases (ERN-Lung). She is chair of the multidisciplinary ILD centre. Her research interests include e-health, patient centred outcome measures in ILD, cough in ILD and new therapies in ILD and sarcoidosis. Dr Wijsenbeek-Lourens is chair of group 12.01 (IIP) of the European Respiratory Society, chair of the functional committee for continued education of the ERN-Lung, member of the scientific advisory board of the European Idiopathic Pulmonary Fibrosis & Related Disorders Federation, and Associate Editor of the European Respiratory Journal.
